Katelyn R. Keyloun
AbbVie (United States)(US)
Publications by Year
Research Areas
Antimicrobial Resistance in Staphylococcus, Antibiotic Use and Resistance, Streptococcal Infections and Treatments, Toxoplasma gondii Research Studies, Bacterial Identification and Susceptibility Testing
Most-Cited Works
- → Toxoplasma gondii calcium-dependent protein kinase 1 is a target for selective kinase inhibitors(2010)185 cited
- → Discovery of Potent and Selective Inhibitors of CDPK1 from C. parvum and T. gondii(2010)138 cited
- → Adherence and Persistence Across Antidepressant Therapeutic Classes: A Retrospective Claims Analysis Among Insured US Patients with Major Depressive Disorder (MDD)(2017)94 cited
- → A Novel Calcium-Dependent Protein Kinase Inhibitor as a Lead Compound for Treating Cryptosporidiosis(2013)77 cited
- → Neospora caninum Calcium-Dependent Protein Kinase 1 Is an Effective Drug Target for Neosporosis Therapy(2014)72 cited
- → Development of potent and selective Plasmodium falciparum calcium-dependent protein kinase 4 (PfCDPK4) inhibitors that block the transmission of malaria to mosquitoes(2014)63 cited
- → Biochemical Screening of Five Protein Kinases from Plasmodium falciparum against 14,000 Cell-Active Compounds(2016)55 cited
- → The gatekeeper residue and beyond: homologous calcium-dependent protein kinases as drug development targets for veterinarian Apicomplexa parasites(2014)55 cited
- → Potent and Selective Inhibitors of CDPK1 from T. gondii and C. parvum Based on a 5-Aminopyrazole-4-carboxamide Scaffold(2013)54 cited
- → Structure determination of glycogen synthase kinase-3 from Leishmania major and comparative inhibitor structure–activity relationships with Trypanosoma brucei GSK-3(2010)41 cited